The Effect of Combination Ovariectomy and D-galactose Administration on Alzheimer's Animal Model
Main Article Content
Abstract
Background and purpose: Animal model helps researchers to evaluate new treatment plan for human and understand pathological mechanism involved in a development of disease. The use of rats as an animal model for Alzheimer's research has become a favorite among researchers. Rats are capable in mimicking Alzheimer disease due to their intelligence and quick adaptation to nature. At present there are several methods that can be used to induce Alzheimer's animals, but each method has advantages and disadvantages. We need to learn other methods that can provide many advantages and few disadvantages. The Amyloid-beta 42 (Aβ-42) and Reactive Oxygen Species (ROS) are thought to play an important role in the pathology of Alzheimer’s disease. This study aims to investigate whether ovariectomy and D-galactose can be an effective method for inducing Alzheimer's animal models.
This was an experimental study with control group design. Twelve female Sprague Dawley rats were involved and grouped into two groups. Control group who did not undergo ovariectomy and the experiment group underwent ovariectomy and was given intraperitoneal D-galactose 500 mg/kg.bw. Amyloid beta-42 plasma and Y-Maze test were conducted after 6 weeks. The results showed that the experiment group has lower mean Y-Maze score (42,79 ± 6,97) compared with control group (74,27 ± 4,01) and the Amyloid-beta 42 plasma was higher in the control group. In conclusion ovariectomy and D-galactose are proven to induce cognitive decline and higher plasma Amyloid-beta 42 in the Alzheimer’s animal model.
Received 19/8/2020
Accepted 11/7/2021
Published Online First 20/3/2022
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Zhang T, Han Y, Wang J, Hou D, Deng H, Deng YL, Song Z. Comparative Epidemiological Investigation of Alzheimer’s Disease and Colorectal Cancer: The Possible Role of Gastrointestinal Conditions in the Pathogenesis of AD. Front. Aging Neurosci. 2018 ; 10:176.
Mayeux R, Stern Y. Epidemiology of Alzheimer's disease. Cold spring harb perspect med. 2012 ; 2(8):269–73.
Benedikz E, Ewa K, Winblad B. The Rat as an animal model for Alzheimer Disease. J Cell mol med. 2009; 13(6):1032-42.
Götz J, Bodea L ,Goedert M. Rodent models for Alzheimer disease. Nat Rev Neurosci. 2018; 19:583–98.
Yuki S, Okanoya K. Rats Show Adaptive Choice in a Metacognitive Task With High Uncertainty. Journal of Experimental Psychology: Animal Learning and Cognition. 2017 ; 43( 1):109 –18.
Gao J, He H, Jiang W, Chang X, Zhu L, Luo F, et al. Salidroside ameliorates cognitive impairment in a D-galactose-induced rat model of Alzheimer’s disease. Behav Brain Res. 2015 ; 93:27–33.
Ali AA, Ahmed HI, Abu-Elfotuh K. Modeling stages mimic Alzheimer’s disease induced by different doses of aluminum in rats: focus on progression of the disease in response to time. J Alzheimers Parkinsonism Dement. 2016;1–11.
Chiroma SM, Mohd MMA, Mat Taib CN, Baharuldin MTH, Amon Z. d-galactose and aluminium chloride induced rat model with cognitive impairments. Biomed Pharmacother. 2018;103:1602-8.
Brinton RD. Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer’s disease. Adv Drug Deliv Rev. 2008; 60 :1504–11.
Henderson VW. Cognitive Changes after menopause : Influence of estrogen. Clin Obstet Gynecol. 2008 ; 51(3) : 618-26.
Henderson VW, St John JA, Hodis HN, McCleary CA, Shoupe D, Stanczyk FZ, et al. Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis. Neurology. 2016 ; 87(7):699-708.
Bowen RL ,Atwood CS. Living and Dying for Sex. Gerontol. 2004; 50(5):265–90.
Lei Y, Renyuan Z. Effects of Androgens on the Amyloid-β Protein in Alzheimer's Disease. Endocrinology. 2018 : 159(12):3885–94.
Gray NE, Zweig JA, Kawamoto C, Quinn JF, Copenhaver PF. STX, a novel membran estrogen Receptor Ligand, Protects Againts Amyloid-β Toxicity. J Alzheimer Dis. 2016 ; 51(2):391-403.
Agca C, Klakotsaia D, Stopa EG, Schachtman T, Agca Y. Ovariectomy Influences Cognition and Markers of Alzheimer’s Disease. J Alzheimer Dis. 2020:529 – 41.
Miedel CJ. Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenik Mouse Models of Amyloid-β and Tau Neuropathology. J Vis Exp. 2017; 12:1-12.
Yu-bin J, Li Z, Xin G, Wei C, Hong-jian Z. Study on cognitive impairment in diabetic rats by different behavioral experiment. 2017. IOP Conf. Ser : Earth Environt. Sci.
Chen CF, Lang SY, Zuo PP, Yang N, Wang XQ, Xia C. Effect of D-Galaktosa on the expression of hippocampal peripheral-type benzodiazepine receptor and spatial memory performance in rats. Psychoneuroendocrinol. 2006 ; 7 : 805-1.
Aydin F, Kalaz EB, Kucukgergin C, Coban J, Dogru-Abbasoglu S, Uysal M. Carnosine Treatment Diminished Oxidative Stress and Glycation Products in Serum and Tissues of D-Galactose-Treated Rats. Curr Aging Sci. 2018;11(1):10-15.
Casadeus G, Webber KM, Atwood CS, Pappolla MA, Perry G, Bowen RL, et al. Lutenizing hormones modulates cognition and amyloid-β deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta. 2006; 4:447-52
Peng N, Clark JT, Prasain J, Kim H, White CR, Wyss JM. Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2005 ; 289(3): 771-5.
Khajuria DK, Razdan R, Mahapatra DR. Description of a new method of ovariectomy in female rats. Rev Bras Reumatol. 2012; 52(3):462-70.
Parameshwaran K, Michael HI, Kosta S, Carl AP. D-galactose Effectiveness in Modeling Aging and Therapeutic Antioxidant Treatment in Mice. Rejuv Research.2010 ; 13:1-9.
Koffe RM, Hyman BT, Spires-Jones TL. Alzheimers disease : synapse gone cold. Mol Neurodegener. 2011 ; 6 :63-71.
Peña-Bautista C, Baquero M, Vento M, Cháfer-Pericás C. Free radicals in Alzheimer's disease: Lipid peroxidation biomarkers. Clinica Chimica Acta. 2019 ; 491: 85-90.